imiquimod has been researched along with indole-3-carbinol in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernard, HU | 1 |
Bryant, A; Dickinson, HO; Kaushik, S; Nordin, A; Pepas, L | 1 |
Bryant, A; Kaushik, S; Lawrie, TA; Nordin, A; Pepas, L | 1 |
Bryant, A; Chakrabarti, M; Kaushik, S; Lawrie, TA; Nordin, A; Pepas, L | 1 |
Alalaiwe, A; Fang, JY; Huang, TH; Lin, ZC; Weng, JR | 1 |
4 review(s) available for imiquimod and indole-3-carbinol
Article | Year |
---|---|
Established and potential strategies against papillomavirus infections.
Topics: Aminoquinolines; Antimetabolites; Antiviral Agents; Cidofovir; Cytosine; Drug Design; Fluorouracil; Humans; Imiquimod; Indoles; Interferon Inducers; Interferons; Organophosphonates; Organophosphorus Compounds; Papillomavirus Infections; Podophyllin; Viral Vaccines | 2004 |
Medical interventions for high grade vulval intraepithelial neoplasia.
Topics: Administration, Topical; Adult; Aminoquinolines; Anticarcinogenic Agents; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Indoles; Randomized Controlled Trials as Topic; Vulvar Neoplasms | 2011 |
Medical interventions for high-grade vulval intraepithelial neoplasia.
Topics: Administration, Topical; Adult; Aminoquinolines; Anticarcinogenic Agents; Antineoplastic Agents; Carcinoma in Situ; Cidofovir; Cytosine; Female; Humans; Imiquimod; Indoles; Organophosphonates; Randomized Controlled Trials as Topic; Vulvar Neoplasms | 2015 |
Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Cidofovir; Cytosine; Disease Progression; Female; Humans; Imiquimod; Indoles; Laser Therapy; Neoplasm Recurrence, Local; Organophosphonates; Photochemotherapy; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome; Vulvar Neoplasms | 2016 |
1 other study(ies) available for imiquimod and indole-3-carbinol
Article | Year |
---|---|
Cutaneous delivery of [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol, an indole-3-carbinol derivative, mitigates psoriasiform lesion by blocking MAPK/NF-κB/AP-1 activation.
Topics: Administration, Cutaneous; Animals; Cell Line; Drug Delivery Systems; Humans; Imiquimod; Indoles; Male; Methanol; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinases; NF-kappa B; Nitrobenzenes; Phosphorylation; Psoriasis; Transcription Factor AP-1; Tumor Necrosis Factor-alpha | 2019 |